COVID-19 in Patients with Hematologic Diseases
The COVID-19 outbreak had a strong impact on people’s lives all over the world. Patients with hematologic diseases have been heavily affected by the pandemic, because their immune system may be compromised due to anti-cancer or immunosuppressive therapies and because diagnosis and treatment of their...
Main Authors: | Ilaria Carola Casetti, Oscar Borsani, Elisa Rumi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/12/3069 |
Similar Items
-
COVID-19 vaccine-induced immune thrombotic thrombocytopenia
by: A. B. Sugraliyev, et al.
Published: (2022-06-01) -
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
by: Archrob Khuhapinant, et al.
Published: (2021-09-01) -
Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
by: Hung-Chen Lin, et al.
Published: (2023-02-01) -
Thrombosis with thrombocytopenia after first dose of ChAdOx1 nCoV-19 vaccine: a case report
by: K. Kolodynskaja, et al.
Published: (2021-12-01) -
A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
by: Abhinandan Chittal, et al.
Published: (2021-11-01)